Detalles de la búsqueda
1.
Continuous enzalutamide after progression of metastatic castration-resistant prostate cancer treated with docetaxel (PRESIDE): an international, randomised, phase 3b study.
Lancet Oncol
; 23(11): 1398-1408, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36265504
2.
Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancer.
BMC Cancer
; 15: 384, 2015 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-25956750
3.
Evaluation of CpG Island Methylator Phenotype as a Biomarker in Colorectal Cancer Treated With Adjuvant Oxaliplatin.
Clin Colorectal Cancer
; 15(2): 164-9, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26702772
4.
Immune response gene expression in colorectal cancer carries distinct prognostic implications according to tissue, stage and site: a prospective retrospective translational study in the context of a hellenic cooperative oncology group randomised trial.
PLoS One
; 10(5): e0124612, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25970543
5.
PAI-1 and HER2 interaction in advanced breast cancer disease: evidence for added benefit from trastuzumab in HER2-negative patients.
Cancer Chemother Pharmacol
; 75(6): 1289-301, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25947084
Resultados
1 -
5
de 5
1
Próxima >
>>